SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 53.85-4.5%Jan 9 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: rkrw who wrote (21260)9/15/2006 2:52:49 PM
From: dr.praveen  Read Replies (1) of 52153
 
American Society of Human Genetics, New Orleans, October 10-14

112638 Phase 1 Data, Key Amicus Data in Fabry’s

Amicus will present data for two drug candidates:

A phase 2 study of Amigal in Fabry’ disease

Phase 1 study of AT2101 in healthy volunteers as well as data from an ex-vivo study evaluating this drug in cells from Gauchers’ disease patients.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News